References
- Ceaser M. Court ends Colombia’s abortion ban. The Lancet. 2006;367(9523):1645–1646. doi:https://doi.org/10.1016/S0140-6736(06)68715-1.
- González Velez AC, Castro L. Barreras de Accesso a la Interrupcion Voluntaria del Embarazo en Colombia. Bogotá: La Mesa por la Vida y la Salud de las Mujeres; 2017.
- Prada E, Biddlecom A, Singh S. Induced abortion in Colombia: new estimates and change between 1989 and 2008. Int Perspect Sex Reprod Health. 2011;37(3):114–124. doi:https://doi.org/10.1363/3711411.
- González Vélez AC, Bohorquez Monsalve V, Castro González L, et al. (2016). Las causales de la ley y la causa de las mujeres. La implementación del aborto legal en Colombia: 10 años profundizando la democracia. La Mesa por la Vida y la Salud de las Mujeres.
- Moore AM, Blades N, Ortiz Romero J, et al. Women’s experiences accessing and using misoprostol acquired through the informal sector in Colombia. BMJ Sex Reprod Health. 2020;46(4):294–300.
- De Zordo S. The biomedicalisation of illegal abortion: the double life of misoprostol in Brazil. História, Ciências, Saúde-Manguinhos. 2016;23(1):19–36. doi:https://doi.org/10.1590/S0104-59702016000100003.
- Zamudio L, Rubiano N, Wartenberg L, et al. El aborto inducido en Colombia: características demográficas y socioculturales. Cuadernos del CIDS. 1999;3:15–157.
- Lafaurie MM, Grossman D, Troncoso E, et al. Women’s perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: A qualitative study. Reprod Health Matters. 2005;13(26):75–83. doi:https://doi.org/10.1016/S0968-8080(05)26199-2.
- Rostagnol S, Viera M, Grabino V, et al. (2013). Transformaciones y continuidades de los sentidos del aborto voluntario en Uruguay: Del AMEU al misoprostol. http://clacaidigital.info:8080/xmlui/handle/123456789/995.
- Baum S, DePiñeres T, Grossman D. Delays and barriers to care in Colombia among women obtaining legal first- and second-trimester abortion. Int J Gynaecol Obstet: Off Organ Int Fed Gynaecol Obstet. 2015;131(3):285–288. doi:https://doi.org/10.1016/j.ijgo.2015.06.036.
- DePiñeres T, Raifman S, Mora M, et al. “I felt the world crash down on me”: women’s experiences being denied legal abortion in Colombia. Reprod Health. 2017;14(1):133, doi:https://doi.org/10.1186/s12978-017-0391-5.
- Singh S, Remez L, Sedgh G, et al. Abortion worldwide 2017. Uneven progress and unequal access. New York: Guttmacher Institute; 2019.
- World Health Organization. Health worker roles in providing safe abortion care and post-abortion contraception. World Health Organization; 2015.
- Gerdts C, Jayaweera RT, Baum SE, et al. Second-trimester medication abortion outside the clinic setting: An analysis of electronic client records from a safe abortion hotline in Indonesia. BMJ Sexual and Reproductive Health. 2018: 286–291. doi:https://doi.org/10.1136/bmjsrh-2018-200102.
- Gerdts C, Jayaweera RT, Kristianingrum IA, et al. Effect of a smartphone intervention on self-managed medication abortion experiences among safe-abortion hotline clients in Indonesia: A randomized controlled trial. Int J Gynecol Obstet. 2020;149(1):48–55. doi:https://doi.org/10.1002/ijgo.13086.
- Sedgh G, Filippi V, Owolabi OO, et al. Insights from an expert group meeting on the definition and measurement of unsafe abortion. Int J Gynecol Obstet. 2016;134(1):104–106. doi:https://doi.org/10.1016/j.ijgo.2015.11.017.
- Moore AM, Philbin J, Ariawan I, et al. Online misoprostol sales in Indonesia: A quality of care assessment. Stud Fam Plann. 2020;51(4):295–308.
- Stillman M, Owolabi O, Fatusi AO, et al. Women’s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria. BMJ Open. 2020;10(5).
- Departamento Adminstrativo Nacional de Estadistica. (2019). Resultados del proceso de omisión censal para el Censo Nacional de Población y Vivienda 2018. Departamento Adminstrativo Nacional de Estadistica. https://www.dane.gov.co/files/censo2018/informacion-tecnica/cnpv-2018-omision-censal.pdf.
- Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. Thousand Oaks (CA): SAGE; 1994.
- World Health Organization. Medical management of abortion. World Health Organization; 2018.
- World Health Organization. (2012). Safe abortion: Technical and policy guidance for health systems. World Health Organization. http://www.who.int/reproductivehealth/publications/unsafe_abortion/9789241548434/en/.
- World Health Organization. Clinical practice handbook for safe abortion. World Health Organization; 2014.
- Blanchard K, Shochet T, Coyaji K, et al. Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception. 2005;72(2):91–97. doi:https://doi.org/10.1016/j.contraception.2005.02.008.
- Kulier R, Kapp N, Gülmezoglu AM, et al. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011;2011(11), doi:https://doi.org/10.1002/14651858.CD002855.pub4.
- Alexander NJ, Baker E, Kaptein M, et al. Why consider vaginal drug administration? Fertil Steril. 2004;82(1):1–12. doi:https://doi.org/10.1016/j.fertnstert.2004.01.025.
- Ngai SW, Tang OS, Chan YM, et al. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability. Hum Reprod. 2000;15(5):1159–1162. doi:https://doi.org/10.1093/humrep/15.5.1159.
- Carbonell JL, Varela L, Velazco A, et al. The use of misoprostol for abortion at ≤ 9 weeks’ gestation. Eur J Contracept Reprod Health Care. 1997;2(3):181–185. doi:https://doi.org/10.3109/13625189709167474.
- Carbonell JLL, Rodríguez J, Velazco A, et al. Oral and vaginal misoprostol 800 μg every 8 h for early abortion. Contraception. 2003;67(6):457–462. doi:https://doi.org/10.1016/S0010-7824(03)00043-X.
- Zikopoulos KA, Papanikolaou EG, Kalantaridou SN, et al. Early pregnancy termination with vaginal misoprostol before and after 42 days gestation. Hum Reprod. 2002;17(12):3079–3083. doi:https://doi.org/10.1093/humrep/17.12.3079.
- World Health Organization. Substandard and falsified medical products. World Health Organization; 2018; https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products.
- World Health Organization. WHO global surveillance and monitoring system for substandard and falsified medical products. World Health Organization; 2017.
- Raymond EG, Shochet T, Blum J, et al. Serial multilevel urine pregnancy testing to assess medical abortion outcome: A meta-analysis. Contraception. 2017;95(5):442–448. doi:https://doi.org/10.1016/j.contraception.2016.12.004.